Table 3.
Cox regression analysis identifying independent variables predictive of virological response.
| Variables | HR (95% CI) | p |
|---|---|---|
| Gender | 0.522 (0.273–0.997) | 0.07 |
| Age | 1.005 (0.966–1.045) | 0.81 |
| Height | 1.018 (0.974–1.063) | 0.43 |
| Weight | 0.994 (0.965–1.024) | 0.68 |
| Alcohol history | 1.158 (0.677–1.983) | 0.59 |
| Smoking history | 0.967 (0.558–1.675) | 0.90 |
| Family history | 1.739 (1.083–2.794) | 0.07 |
| ALT baseline (U/L) | 1.000 (0.998–1.002) | 0.84 |
| HBV DNA baseline (log10 IU/mL) | 0.904 (0.699–1.169) | 0.44 |
| Therapy with TDF versus ETV | 0.896 (0.552–1.457) | 0.66 |
TDF, tenofovir; ETV, entecavir; ALT, alanine aminotransferase; IU/mL, international unit per milliliter; U/L, unit per liter; HR, hazard ratio; CI, confidence interval.